AkzoNobel, NL0013267909

AkzoNobel with clear analyst view, consensus points to upside for the shares

23.06.2026 - 23:14:10 | ad-hoc-news.de

AkzoNobel starts the trading week with a stable consensus picture. Several houses keep Buy ratings in place, while average price targets from MarketScreener imply upside from current levels.

AkzoNobel, NL0013267909
AkzoNobel, NL0013267909

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 23:13.

AkzoNobel (NL0013267909) enters the new week with a broadly constructive analyst stance. According to the latest consensus overview on MarketScreener, several banks rate the stock Buy, and the average price target still signals double-digit percentage upside from current Amsterdam levels.

What analysts are signaling

For AkzoNobel, MarketScreener shows a mix of Buy and Hold recommendations from international houses, with only a minority on Sell, giving the stock a balanced but slightly positive profile in the chemicals sector. MarketScreener consensus for AkzoNobel The average target price on that platform stands notably above the current quote on Euronext Amsterdam, implying potential upside in the low double-digit percentage range based on recent trading data.

Analyst coverage focuses on continued margin discipline and cost programs following the group’s recent portfolio adjustments in decorative and performance coatings, while peers such as BASF and PPG Industries remain key reference points in European and US chemicals. Reuters analyst estimates page for AkzoNobel In several notes, brokers emphasize the sensitivity of earnings to raw material prices and construction activity, factors that also drive sentiment for rivals like Sherwin-Williams and Nippon Paint.

What the numbers suggest for 2026

Consensus data compiled by MarketScreener indicate that analysts currently expect AkzoNobel to grow sales modestly in the low single-digit percentage range for the 2026 financial year, with a gradual improvement in operating margins versus prior years. MarketScreener financial estimates for AkzoNobel Earnings per share projections rise accordingly, with the median estimate showing a noticeable increase compared with the latest reported twelve-month period.

The same estimates also point to a continued dividend stream, with an expected payout that keeps the dividend yield in a competitive range for a European mid-to-large cap chemicals name, although exact figures differ slightly from house to house. Bloomberg quote and dividend data for AkzoNobel Several analysts explicitly mention the company’s leverage profile and free cash flow generation as key metrics to watch when comparing AkzoNobel to sector peers in indices such as the STOXX Europe 600.

Go deeper

All news and data on the AkzoNobel shares

Price data, news and further consensus figures on AkzoNobel are available in the dedicated topic area and on the company’s investor relations page.

The coatings business behind the stock

AkzoNobel generates its revenue primarily in paints and coatings, including decorative paints for buildings and performance coatings for industrial applications. A flagship consumer-facing line is its Dulux decorative paints brand, which is sold in many markets worldwide through retail channels and professional distributors.

Where the shares trade today

The AkzoNobel shares (NL0013267909) last traded on Euronext Amsterdam at around 70 euros on 2026-06-23, 17:35, according to recent exchange data, with the listing included in major European benchmarks such as the STOXX Europe 600.

Key data on the AkzoNobel shares

  • Company: Akzo Nobel N.V.
  • ISIN: NL0013267909
  • WKN: A2PX4R
  • Ticker: AKZA
  • Trading venue: Euronext Amsterdam
  • Price (as of 2026-06-23, 17:35): 70.00 EUR
  • Market cap: 12.0 billion EUR (as of 2026-06-23)
  • Sector / industry: Materials / Specialty Chemicals, Paints & Coatings
  • Index membership: STOXX Europe 600
  • Next earnings date: 2026-07-18

More on the AkzoNobel shares in social media

This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer or solicitation to buy or sell any financial instrument. Investors should conduct their own research and consider their individual financial situation before making investment decisions.

en | NL0013267909 | AKZONOBEL | boerse | 69614080 | bgmi